Tag: CureVac Stock Pricing
German biotechnology firm CureVac raises $213.3 million Initial Public Offering on Nasdaq
German CureVac BV stock market debut of a company developing a potential vaccine to combat the coronavirus. The German biotechnology firm, backed by Microsoft Corp […]